Consequently, based on our current study, we believe that Ethyl 2-[5-(4-chlorophenyl)-2-methyl-1-H-Imidazole-4-yl] acetate potentially inhibits nuclear sirtuins, especially the expression of Sirt6 and regulates cancer progression. The gene discussed is SIRT6; the disease is cancer.